Call for Abstracts
Researchers, healthcare professionals, regulators, industry experts, and students are invited to submit abstracts for participation in the Pharmacovigilance Symposium. The symposium aims to advance knowledge, innovation, and best practices in medication safety and pharmacovigilance.
1. Who Can Apply?
Abstract submissions are welcome from all individuals and groups with an interest in medication safety, including but not limited to:
- Pharmacovigilance professionals
- Clinicians and healthcare providers (physicians, pharmacists, nurses, etc.)
- Regulatory authorities and policymakers
- Regulatory Affairs professionals
- Medical Affairs professionals
- Market Access professionals
- Pharmaceutical and biotechnology industry professionals
- Medical device and combination product specialists
- Data scientists and AI specialists in healthcare
- Researchers and academics
- Clinical trial professionals
- Early Career & Public Engagement
- Undergraduate and MSc students
- Early-career professionals
- Anyone with a demonstrated interest in medication safety
2. Abstract Themes & Topics
Submitted abstracts must align with one primary theme from the following areas:
- Artificial Intelligence (AI) and digitalization in pharmacovigilance
- Risk management and effectiveness of risk minimization measures (RMMs)
- Pharmacovigilance communication
- Pharmacovigilance education and professional qualification
- PV regulation (compliance, audits, inspections, regulatory convergence, reliance, and regulatory affairs interaction)
- Real-World Evidence (RWE)
- Digital healthcare and pharmacovigilance integration
- Pharmacovigilance in healthcare practice
- Patient engagement in medication safety
- Safety in clinical trials
- Medical device and combination product safety
- Safety in special populations (women’s medicines, teratovigilance, pediatrics, geriatrics)
- Vaccines and biotechnology/biosimilars
- Herbal, traditional medicines, and cosmetics
- Safe use of medicinal products:
- Counterfeit and substandard medicines
- Pharmacovigilance and market access: from safety evaluation to safe availability
3. Presentation Format
- Abstracts may be submitted for: Poster presentation
4. Abstract Preparation Guidelines
Title
- Must be written in UPPER CASE (or Title Case if specified by the submission system)
Abstract Text
- Word limit: 300–400 words (as specified in the submission platform)
- Text only (no tables, figures, or images)
Mandatory Structure
Abstracts must include the following sections:
- Background / Objective
- Study rationale and purpose
- Methods
- Study design, population, data sources, and analysis
- Results
- “Results pending” is generally not acceptable
- Conclusion
- Main conclusions and relevance to pharmacovigilance practice or policy
5. Author & Submission Requirements
- At least one author (presenting author) must:
- Attend the conference in person
- Register for the conference upon abstract acceptance
- Each submission requires a unique email address
- Author list must include:
- Full first and last names
- Institutional affiliation (department, organization, city, country)
- Author order and spelling are final upon submission and cannot be changed
6. Eligibility & Publication Policy
- Abstracts must be original work
- Abstracts that have been:
- Based on already published full papers
7. Submission Categories (Presenting Author)
Applicants must select one category:
- Student (Undergraduate or MSc only)
- Other Professional (e.g., researcher, scientist, regulatory affairs)
- Other (with specification)
8. Terms & Conditions
By submitting an abstract, the presenting author confirms that:
- The information provided is accurate and complete
Withdrawal Deadline
- Abstract withdrawal deadline: April 15, 2026
- Requests must be submitted via email
9. Contact Information
For abstract-related inquiries or withdrawal requests, please contact:
📧 spvsa2024@gmail.com
